The remaining four DElncRNAs (MEG3, maternally expressed gene 3; RMST, rhabdomyosarcoma 2-associated transcript; HNF1A-AS1, HNF1A antisense RNA 1; and PVT1, and plasmacytoma variant translocation 1) and two DEmiRNAs (hsa-mir-429 and hsa-mir-200a) appeared to be protective (Figures 7(d) and 7(i)). This evidence concerns the gene HNF1A and rhabdomyosarcoma.